Skip to content

Dossier · GENI · Dormant

GENI · Genius Sports Limited · Stock research

Last analysed ·

Current thesis

Sports-data toll-booth under the prediction-market boom, but the boom arrived and the toll didn't: Kalshi/Polymarket cleared $50B+ of World Cup volume (Coindesk, 2026-07-14) while GENI slid $6.43 → $6.30 and printed $5.98 intraday July 17. Theme accelerating, stock diverging. Aug 5–11 Q2 print is the first place the data revenue must appear in dollars.

Invalidation trigger

A weekly close below $5.70 breaks the June post-Polymarket base low and confirms the toll-booth thesis is not being paid; secondary break if the Aug 5–11 Q2 print again quantifies no prediction-market data revenue or walks the FY26 $270–280M adj-EBITDA guide.

Thesis status

Invalidated resolved published trigger fired How this is scored →

Latest analysis and events for GENI —

As of 2026-07-28, orbyd's latest analysis for Genius Sports Limited (GENI): Sports-data toll-booth under the prediction-market boom, but the boom arrived and the toll didn't: Kalshi/Polymarket cleared $50B+ of World Cup volume (Coindesk, 2026-07-14) while GENI slid $6.43 → $6.30 and printed $5.98 intraday July 17. Theme accelerating, stock diverging. Aug 5–11 Q2 print is the first place the data revenue must appear in dollars.

Invalidation trigger: A weekly close below $5.70 breaks the June post-Polymarket base low and confirms the toll-booth thesis is not being paid; secondary break if the Aug 5–11 Q2 print again quantifies no prediction-market data revenue or walks the FY26 $270–280M adj-EBITDA guide.

Current Thesis

The setup was supposed to work like this: prediction markets need settlement-grade official data, Genius sells it, volume growth converts into a high-margin data annuity. Six weeks of live evidence now sit against that. Kalshi and Polymarket cleared more than $50B in volume across the World Cup group and knockout stages — Coindesk (2026-07-14) framed it as prediction markets outrunning traditional sportsbooks outright — and GENI went the other way, from $6.43 (July 2) to $6.30 (July 17 close) with a $5.98 intraday print that same session. The theme did everything the bull case asked of it. The equity did not respond.

That divergence is the whole read. A picks-and-shovels name whose end market just printed record throughput should not be sitting 43% below where it traded a year ago, nine percent above its June base low, with the demand event now finished. Either the toll-booth is collecting and the market has not priced it, or the toll-booth is not collecting. The Aug 5–11 Q2 print is the first disclosure that settles it, and there is no dated company catalyst between now and then. Trades on a US exchange, so directly playable — but the honest classification right now is a broken chart wearing an intact story.

Bullish and bearish views on Genius Sports Limited

The model's bull view on Genius Sports Limited (GENI), in brief: Prediction-market throughput is compounding, not cresting — combined Polymarket/Kalshi volume ran from under $5B/month (Sept 2025) to $24B (April 2026) to a World Cup stretch above $50B (Coindesk, 2026-07-14). The bear view: The stock failed into the largest catalyst it will get this year. Both cases follow in full.

Bull Case

  • Prediction-market throughput is compounding, not cresting — combined Polymarket/Kalshi volume ran from under $5B/month (Sept 2025) to $24B (April 2026) to a World Cup stretch above $50B (Coindesk, 2026-07-14). Kalshi alone hit $1B on a single winner market. This is the fastest-growing demand curve in sports wagering.
  • June 10 2026 Liga MX / Polymarket / Genius arrangement — Polymarket named exclusive US prediction-market partner with Genius supplying official data and integrity services for contract creation and settlement. The first public proof that prediction-market contracts route through the GENI feed rather than around it.
  • CFTC is legitimising the category, not killing it — the June 10 2026 Notice of Proposed Rulemaking explicitly permits sports event contracts on final scores, point differentials, win-loss, tournament advancement and statistical performance. Prohibitions are narrow (single-play markets, injuries, officiating, pre-collegiate). Regulatory clarity is the stated blocker to GENI monetising these counterparties; the proposal removes it.
  • Q1 2026 (May 8) — group revenue +31% YoY, adj EBITDA +21%, betting +33%, media +22%. FY26 guide lifted to $990M–$1.01B revenue and $270–280M adj EBITDA versus a pre-Legend $810–820M / $180–190M, stepping midpoint margin to ~28% from 23%.
  • Legend combination widens the take-rate — the ~$1.2B deal adds a betting-affiliate network, so Genius earns on customer acquisition alongside data licensing. Management called prediction markets the specific synergy: the ecosystem needs official data plus high-value audiences, and only very early stages of that opportunity sit inside current guidance.
  • Sell-side has not capitulated — 18 analysts at Strong Buy, average target $10.19, roughly 62% above the $6.30 spot.

Bear Case

  • The stock failed into the largest catalyst it will get this year. The World Cup ran June 11 to July 19 2026 with global wagers projected above $50B (Macquarie) and US handle near $3.3B (Deutsche Bank). GENI drifted the entire way and closed the window at $6.30. When a name cannot rally on its own best news, the next disappointment does not have a cushion.
  • No dollar figure has ever been disclosed. Prediction-market arrangements remain described as "official data and integrity" with no quantified revenue line as of July 2026. Pre-Legend commentary went further: Genius had not sold data to Kalshi or Polymarket at all, citing regulatory uncertainty on those platforms. The June Liga MX deal cuts against that, and the tension is unresolved in public disclosure.
  • The catalyst calendar is empty and then binary. World Cup finished July 19. Nothing dated sits between the final and the Q2 print. Guidance for Q2 is specific — approximately $185M group revenue and $45M group adj EBITDA on one month standalone plus two months combined — which makes it easy to miss visibly.
  • Leverage narrows the error bar. The Legend acquisition carries an $825M term loan. TTM net income is -$158.85M against $713M revenue. An EBITDA shortfall is amplified by the capital structure rather than absorbed by it.
  • Not exclusive, and the peer moved first. Sportradar signed Kalshi on June 8 2026 across soccer, baseball, hockey and UFC. Two vendors serve the same counterparties, which caps pricing power on renewal and turns the "surefire winner either way" framing into a margin question.
  • Sell-side is trimming while staying constructive — Citi cut to $9 from $11 in May 2026 keeping Buy; the consensus average has compressed toward $10.19. Targets drifting down while price drifts down is not a divergence to lean on.

Setup & Price Structure

  • Spot $6.30 (July 17 2026 close, +0.32%), with a $5.98 low intraday that session. Market cap ~$1.69B, high-beta small cap near 1.9.
  • 52-week range $3.83–$13.73. The stock is 54% below its 52-week high and -43% on the year. Structurally this is a downtrend, and the June Polymarket pop was a counter-trend spike inside it.
  • The June 10 news lifted price to roughly $7.11 intraday and $7.03 on June 12. That level has not been retested. The sequence since is a series of lower highs into the $5.70 June base low.
  • $5.70 is the level that matters. It is the shelf the post-Polymarket move built from, and the July 17 print at $5.98 put price within thirty cents of testing it. Losing it on a weekly basis retires the entire June breakout structure.
  • Anything bought here is bought into weakness with no reclaim of the June high and no completed base. A constructive re-entry needs price back above the $7.03–$7.11 June resistance shelf on volume, ideally with a Q2 disclosure behind it.

Catalyst Calendar (next 30 days)

  • ~2026-08-05 to 2026-08-11, est. — Q2 2026 results. Sources conflict on the exact date; treat the whole window as blackout. Three things get graded: whether the ~$185M / ~$45M Q2 guide is hit, whether the FY26 $270–280M adj EBITDA guide holds, and whether prediction-market data revenue is quantified in dollars for the first time.

Elapsed catalysts

  • 2026-07-19 — FIFA World Cup Final, Spain vs Argentina, New York/New Jersey. The last demand event of the cycle. Volume records here are already largely reflected in the $50B+ tally and should not be treated as fresh news. (passed 21d ago)
  • 2026-07-27 — CFTC comment deadline on the prediction-market event-contract NPRM. Not a revenue event, but the closing of the comment window is the gate before final rule adoption, which is the mechanism that would unblock GENI selling data directly into Kalshi and Polymarket at scale. Final adoption has no published date. (passed 13d ago)

What Would Change Our Mind

  • Bullish re-rate: the Q2 call puts a disclosed dollar figure on prediction-market data and integrity revenue with a stated ramp, and price reclaims the $7.03–$7.11 June shelf on expanding volume. That converts the story from a partnership headline into an annuity, and the $10.19 consensus target stops looking stale.
  • Bullish, second path: CFTC adopts the final rule substantially as proposed and Genius announces direct, named commercial agreements with Kalshi or Polymarket carrying disclosed economics.
  • Bearish confirmation: a weekly close below $5.70. That level is the June base and the last structure the June narrative built. Below it, the picks-and-shovels framing has been tested against the biggest sports-wagering event available and failed on the tape.
  • Bearish, fundamental: the Q2 print again describes prediction markets qualitatively with no revenue line, or the FY26 EBITDA guide is walked back. Either outcome means the levered balance sheet is carrying a story rather than a business inflection.
  • Read-through trigger: Sportradar discloses prediction-market economics before or alongside GENI. That would reframe the situation from sector-wide timing to competitive share loss.

Correlation Notes

  • Sportradar (SRAD) is the closest comparable and the direct co-vendor. The pair should trade together on prediction-market policy news; persistent SRAD outperformance through the August prints is the cleanest evidence that GENI-specific execution is the problem.
  • Prediction-market complex — private throughput at Kalshi and Polymarket is the demand driver, but there is no listed proxy for it, which means the theme can accelerate without any equity capturing it. That is the exact failure mode visible in the June–July tape.
  • Regulated sportsbooks (DKNG, FLUT) are on the other side of the trade. Prediction markets taking World Cup share from traditional books pressures them, and GENI supplies both, so the pairing is a hedge on the substitution question rather than a directional bet.
  • Small-cap high-beta — near-1.9 beta and a $1.69B cap mean GENI amplifies Russell-level risk moves. Positioning here carries index beta on top of single-name risk, which matters into an August print with a levered balance sheet.
  • Theme status: ACCELERATING at the industry level, deteriorating at the security level. The correct handling of that split is to wait for the equity to confirm the theme rather than to assume it eventually must.

Notes

  • Earnings date sources conflict: stockanalysis.com lists 2026-08-05, marketbeat/consensus lists 2026-08-11. Treat the whole Aug 5-11 window as blackout for fresh entries.
  • Q2 guide is a hard, checkable number: ~$185M group revenue / ~$45M group adj EBITDA (1 month standalone Genius + 2 months combined post-Legend). A miss on either is a straight thesis break, not a wobble.
  • The single unresolved question is whether GENI books prediction-market data revenue as a disclosed line. Pre-Legend commentary framed Kalshi/Polymarket as blocked on regulatory uncertainty; the June 10 Liga MX/Polymarket deal contradicts that. The Q2 call is where the contradiction resolves.
  • CFTC NPRM comment window closes 2026-07-27 — a dated, non-earnings catalyst. Final rule adoption is the real unlock and has no published date.
  • World Cup final played 2026-07-19. The demand event is now behind the tape; there is no seasonal catalyst between the final and the Q2 print.
  • $825M term loan funding the Legend deal means EBITDA slippage is levered. Net income still negative (-$158.85M TTM).
  • Sportradar (SRAD) mans the same toll booth (Kalshi deal 2026-06-08). Watch SRAD's Q2 print as a read-through — if SRAD discloses prediction-market dollars and GENI does not, that is a share-loss signal, not a sector signal.
  • 52-week range $3.83-$13.73; stock -43% over 52 weeks. This is a downtrend with a narrative attached, not a base with a catalyst attached.

Related · shared themes

CME

CME Group Inc.

Incumbent-exchange pivot into event contracts: the 2026-07-29 FutureSports index-futures deal plus record July ADV of 27M contracts (+23% YoY, reported 2026-08-04), against a stock still 16.9% below its 52-week high of $317.22. Operating records are not producing price highs; the leg only confirms above the 200-day near $278.50, and the 2026-08-26 CFTC comment close is the near-term gate.

MEDIUM

FA

First Advantage Corporation

Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first time. A second leg on a labour-cyclical base that is still decelerating; the next test is payrolls, not the company.

MEDIUM

PENN

PENN Entertainment, Inc.

iCasino-led digital turnaround gliding toward Q4-2026 interactive profitability as the regional-gaming cycle re-rates; the June–July sell-side upgrade cluster has now largely fired, leaving an extended name near 52-week highs into the binary 2026-08-06 print — reward/risk favors the $18–19 pullback shelf over chasing.

MEDIUM

CRSR

Corsair Gaming, Inc.

Margin-inflection leg: Q2 FY26 (2026-08-06) delivered adj EPS $0.23 vs $0.07 consensus, a record 33.2% gross margin and an FY26 EPS guide of $0.85–$0.94 vs $0.72 est. Price closed 2026-08-07 at $14.35, the 52-week high and above three of four published targets, with the next company binary not until the ~November Q3 print.

LOW